Samantha McLemore Patient Capital Management
Samantha McLemore is the founder of Patient Capital Management and previously worked closely with Bill Miller on value-oriented strategies. Her firm emphasizes long-term, research-driven equity investing with a willingness to hold unconventional or out-of-favor ideas. McLemore’s portfolio is followed by investors who track the next generation of independent value managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$29.7M |
| 2 |
Kosmos Energy
KOS
|
+$29.3M |
| 3 |
Biogen
BIIB
|
+$26.7M |
| 4 |
Seadrill
SDRL
|
+$25.2M |
| 5 |
Royalty Pharma
RPRX
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travel + Leisure Co
TNL
|
+$38.9M |
| 2 |
Expedia Group
EXPE
|
+$35.3M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$25.1M |
| 4 |
United Airlines
UAL
|
+$23.7M |
| 5 |
SoFi Technologies
SOFI
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 27.73% |
| 2 | Financials | 16.69% |
| 3 | Communication Services | 14.9% |
| 4 | Healthcare | 12.55% |
| 5 | Industrials | 11.57% |
Similar funds
Samantha McLemore's Q4 2024 Portfolio in Review
As of Q4 2024, Samantha McLemore held 43 positions worth $2.17B, up 6.4% from $2.04B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 4.7%. Samantha McLemore opened 2 new positions and made no exits, leaving the 43-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 31% a quarter earlier, followed by Financials and Communication Services.
- Samantha McLemore's largest Q4 2024 buy was JD.com: 100,000 shares worth $3.47M.
- Samantha McLemore added most to CVS Health in Q4 2024, an estimated $29.7M increase.
- Samantha McLemore's biggest Q4 2024 reduction was Travel + Leisure Co, cutting an estimated $38.9M.
- Samantha McLemore's ten largest holdings make up 45% of its $2.17B portfolio in Q4 2024.
- Samantha McLemore opened 2 new positions and closed 0 in Q4 2024.
- Samantha McLemore's portfolio value rose 6.4% quarter-over-quarter to $2.17B.
Based on Patient Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.